Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

LGNDLGND
31 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in LIGAND PHARMACEUTICALS INC

Yes. Deutsche Bank holds 249,611 shares of LGND (Ligand Pharmaceuticals), worth $78.9M, as of its Q2 2026 13F filing. It reduced the position by 56,500 shares (-18.5%) from Q1 2026. Deutsche Bank has held LGND in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$78.9M

Current Shares

249,611

Total Value Change

+$61.3M

Total Shares Change

+119,679

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
249,611
-18.5%
$78.9M0.0%$316.09
0
2026-Q1
Decreased
306,111
-0.6%
$61.1M0.0%$199.65
0
2025-Q4
Increased
307,871
+0.1%
$58.2M0.0%$189.07
29
2025-Q3
Decreased
307,532
-0.1%
$54.5M0.0%$177.14
0
2025-Q2
Increased
307,797
+6.9%
$35M0.0%$113.68
31
2025-Q1
Decreased
287,965
-0.4%
$30.3M0.0%$105.14
0
2024-Q4
Increased
289,052
+5.5%
$31M0.0%$107.15
30
2024-Q3
Increased
273,892
+1.4%
$27.4M0.0%$100.09
29
2024-Q2
Increased
270,224
+14.6%
$22.8M0.0%$84.26
33
2024-Q1
Increased
235,904
+26.9%
$17.2M0.0%$73.10
35
2023-Q4
Increased
185,897
+36.5%
$13.3M0.0%$71.42
36
2023-Q3
Increased
136,229
+43.0%
$8.2M0.0%$59.92
37
2023-Q2
Decreased
95,271
-1.3%
$6.9M0.0%$72.10
0
2023-Q1
Increased
96,502
+91.0%
$7.1M0.0%$73.56
43
2022-Q4
Increased
50,527
+4.0%
$3.4M0.0%$66.80
28
2022-Q3
Decreased
48,608
-2.9%
$4.2M0.0%$53.72
0
2022-Q2
Decreased
50,059
-1.7%
$4.5M0.0%$55.66
0
2022-Q1
Decreased
50,904
-28.7%
$5.7M0.0%$70.17
0
2021-Q4
Increased
71,374
+15.5%
$11M0.0%$96.36
32
2021-Q3
Decreased
61,810
-17.7%
$8.6M0.0%$86.91
0
2021-Q2
Decreased
75,098
-9.4%
$9.9M0.0%$81.84
0
2021-Q1
Decreased
82,885
-2.6%
$12.6M0.0%$95.10
0
2020-Q4
Increased
85,073
+1.2%
$8.5M0.0%$62.04
28
2020-Q3
Decreased
84,090
-17.6%
$8M0.0%$59.46
0
2020-Q2
Increased
102,024
+6.3%
$11.4M0.0%$69.78
30
2020-Q1
Increased
95,975
+24.1%
$7M0.0%$45.36
33
2019-Q4
Increased
77,353
+30.0%
$8.1M0.0%$65.06
35
2019-Q3
Increased
59,499
+22.9%
$5.9M0.0%$62.10
33
2019-Q2
Decreased
48,392
-22.3%
$5.5M0.0%$71.21
0
2019-Q1
Decreased
62,305
-52.0%
$7.8M0.0%$78.42
0
2018-Q4
First report
129,932
-
$17.6M0.0%$84.65
0

Other major holders of LGND: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used